UBS Group »

Novavax shares owned by UBS Group

Quarter-by-quarter ownership of Novavax (NVAX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Novavax

Tip: Access up to 7 years of quarterly data

All positions including Novavax held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novavax by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $841k 175k 4.80
2023-09-30 $425k 59k 7.24
2023-06-30 $3.4M 457k 7.43
2023-03-31 $3.2M 457k 6.93
2022-12-31 $336k 33k 10.28
2022-09-30 $4.9M 272k 18.21
2022-06-30 $9.7M 189k 51.43
2022-03-31 $17M 231k 75.00
2021-12-31 $32M 226k 143.08
2021-09-30 $22M 106k 207.33
2021-06-30 $17M 78k 212.16
2021-03-31 $9.5M 52k 181.30
2020-12-31 $4.5M 40k 111.51
2020-09-30 $6.8M 63k 108.35
2020-06-30 $1.1M 13k 83.39
2020-03-31 $490k 36k 13.59
2019-12-31 $154k 38k 4.10
2019-09-30 $89k 18k 5.03
2019-06-30 $19k 3.2k 5.94